161 related articles for article (PubMed ID: 31403949)
1. Clinical and Pathological Benefits of Edaravone for Alzheimer's Disease with Chronic Cerebral Hypoperfusion in a Novel Mouse Model.
Feng T; Yamashita T; Shang J; Shi X; Nakano Y; Morihara R; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Matsumoto N; Hishikawa N; Ohta Y; Abe K
J Alzheimers Dis; 2019; 71(1):327-339. PubMed ID: 31403949
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of edaravone on white matter pathology in a novel mouse model of Alzheimer's disease with chronic cerebral hypoperfusion.
Feng T; Yamashita T; Sasaki R; Tadokoro K; Matsumoto N; Hishikawa N; Abe K
J Cereb Blood Flow Metab; 2021 Jun; 41(6):1437-1448. PubMed ID: 33106078
[TBL] [Abstract][Full Text] [Related]
3. Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse.
Shang J; Yamashita T; Tian F; Li X; Liu X; Shi X; Nakano Y; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
Brain Res; 2019 Nov; 1723():146379. PubMed ID: 31415766
[TBL] [Abstract][Full Text] [Related]
4. Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits.
Jiao SS; Yao XQ; Liu YH; Wang QH; Zeng F; Lu JJ; Liu J; Zhu C; Shen LL; Liu CH; Wang YR; Zeng GH; Parikh A; Chen J; Liang CR; Xiang Y; Bu XL; Deng J; Li J; Xu J; Zeng YQ; Xu X; Xu HW; Zhong JH; Zhou HD; Zhou XF; Wang YJ
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5225-30. PubMed ID: 25847999
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Pathological Benefits of Scallop-Derived Plasmalogen in a Novel Mouse Model of Alzheimer's Disease with Chronic Cerebral Hypoperfusion.
Feng T; Hu X; Fukui Y; Bian Z; Bian Y; Sun H; Takemoto M; Yunoki T; Nakano Y; Morihara R; Abe K; Yamashita T
J Alzheimers Dis; 2022; 86(4):1973-1982. PubMed ID: 35253748
[TBL] [Abstract][Full Text] [Related]
6. Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer's disease model.
Parikh A; Kathawala K; Li J; Chen C; Shan Z; Cao X; Wang YJ; Garg S; Zhou XF
Drug Des Devel Ther; 2018; 12():2111-2128. PubMed ID: 30022810
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Pathological Benefit of Twendee X in Alzheimer's Disease Transgenic Mice with Chronic Cerebral Hypoperfusion.
Liu X; Yamashita T; Shang J; Shi X; Morihara R; Huang Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1993-2002. PubMed ID: 31029568
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
[TBL] [Abstract][Full Text] [Related]
9. Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia.
Kelliny S; Xiong J; Bobrovskaya L; Zhou XF
Neurotox Res; 2021 Dec; 39(6):1689-1707. PubMed ID: 34599751
[TBL] [Abstract][Full Text] [Related]
10. Acceleration of NLRP3 inflammasome by chronic cerebral hypoperfusion in Alzheimer's disease model mouse.
Shang J; Yamashita T; Zhai Y; Nakano Y; Morihara R; Li X; Tian F; Liu X; Huang Y; Shi X; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
Neurosci Res; 2019 Jun; 143():61-70. PubMed ID: 29885344
[TBL] [Abstract][Full Text] [Related]
11. Chronic cerebral hypoperfusion induces memory deficits and facilitates Aβ generation in C57BL/6J mice.
Wang L; Du Y; Wang K; Xu G; Luo S; He G
Exp Neurol; 2016 Sep; 283(Pt A):353-64. PubMed ID: 27421879
[TBL] [Abstract][Full Text] [Related]
12. Protective Effects of Rivaroxaban on White Matter Integrity and Remyelination in a Mouse Model of Alzheimer's Disease Combined with Cerebral Hypoperfusion.
Bian Z; Hu X; Liu X; Yu H; Bian Y; Sun H; Fukui Y; Morihara R; Ishiura H; Yamashita T
J Alzheimers Dis; 2023; 96(2):609-622. PubMed ID: 37840489
[TBL] [Abstract][Full Text] [Related]
13. Twendee X Ameliorates Phosphorylated Tau, α-Synuclein and Neurovascular Dysfunction in Alzheimer's Disease Transgenic Mice With Chronic Cerebral Hypoperfusion.
Liu X; Yamashita T; Shang J; Shi X; Morihara R; Huang Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104310. PubMed ID: 31383622
[TBL] [Abstract][Full Text] [Related]
14. From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration.
Zhao Y; Gong CX
Cell Mol Neurobiol; 2015 Jan; 35(1):101-10. PubMed ID: 25352419
[TBL] [Abstract][Full Text] [Related]
15. Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer's Disease Model Mouse.
Shang J; Yamashita T; Zhai Y; Nakano Y; Morihara R; Fukui Y; Hishikawa N; Ohta Y; Abe K
J Alzheimers Dis; 2016 Mar; 52(1):113-26. PubMed ID: 27060955
[TBL] [Abstract][Full Text] [Related]
16. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
17. Edaravone attenuates oxidative stress induced by chronic cerebral hypoperfusion injury: role of ERK/Nrf2/HO-1 signaling pathway.
Zhang D; Xiao Y; Lv P; Teng Z; Dong Y; Qi Q; Liu Z
Neurol Res; 2018 Jan; 40(1):1-10. PubMed ID: 29125058
[TBL] [Abstract][Full Text] [Related]
18. Edaravone injection reverses learning and memory deficits in a rat model of vascular dementia.
Li X; Lu F; Li W; Qin L; Yao Y; Ge X; Yu Q; Liang X; Zhao D; Li X; Zhang J
Acta Biochim Biophys Sin (Shanghai); 2017 Jan; 49(1):83-89. PubMed ID: 27864280
[TBL] [Abstract][Full Text] [Related]
19. Chronic cerebral hypoperfusion accelerates Alzheimer's disease pathology with the change of mitochondrial fission and fusion proteins expression in a novel mouse model.
Feng T; Yamashita T; Zhai Y; Shang J; Nakano Y; Morihara R; Fukui Y; Hishikawa N; Ohta Y; Abe K
Brain Res; 2018 Oct; 1696():63-70. PubMed ID: 29879414
[TBL] [Abstract][Full Text] [Related]
20. Edaravone Attenuates Aβ 1-42-Induced Inflammatory Damage and Ferroptosis in HT22 Cells.
Guo S; Lei Q; Guo H; Yang Q; Xue Y; Chen R
Neurochem Res; 2023 Feb; 48(2):570-578. PubMed ID: 36333599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
